Herbs and the FDA: Current Regulation, Problems and Suggestions for Change

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Doogan, Amy	en_US
dc.date.accessioned	2012-06-07T20:15:43Z
dc.date.issued	2002	en_US
dc.identifier.citation	Herbs and the FDA: Current Regulation, Problems and Suggestions for Change (2002 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852135
dc.description.abstract	In this paper, I will discuss the current treatment of herbal products under DSHEA and describe some of the risks of herbal products. I will also talk about current FDA responses to these risks and provide some suggestions for ways in which the federal government could better protect consumers by regulating the marketing of herbal products.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	herbs	en
dc.subject	herbal products	en
dc.subject	DSHEA	en
dc.subject	alternative medicines	en
dc.title	Herbs and the FDA: Current Regulation, Problems and Suggestions for Change	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T20:15:43Z